Pre-emptive Intravenous Morphine for Acute Post-craniotomy Pain.

• Status: Not yet recruiting
• Trial end date: 2023-03-01
• Target enrollment: 0
• Participant gender: All

Summary

We propose a double-blind randomized controlled trial to evaluate the effect of intravenously administered morphine at surgery conclusion on acute postoperative pain in patients recovering from craniotomy surgery. Participating adults having craniotomy surgery will be randomized in a 1:1 ratio to intraoperative intravenous administration of 0.08 mg/kg morphine at dura closure, or a matching placebo.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Tel-Aviv Sourasky Medical Center
• Treatments: Morphine

Criteria

Inclusion Criteria:

• Informed consent.

• Scheduled for elective craniotomy for resection of supra-tentorial intracranial tumor that requires cranium sawing, dural opening and excision of tumor, under general anesthesia.

• Age 18 - 80 years.

• American Society of Anesthesiologists' physical status I-III.

• Body mass index (BMI) under 35 kg/m2.

Exclusion Criteria:

• Pregnant or current breastfeeding patients.

• Patients unable to provide informed consent or in need of a legal authorized representative.

• Patients with neurological disorders preventing a good understanding of the pain numerical reporting scale (NRS) before surgery.

• Patients with pre-operative aphasia.

• Patients with chronic pain or chronic use of opioids.

• Patients with current alcohol or drug abuse.

• Expected delayed extubation.

• Patients with documented allergy to opioids or acetaminophen.

• Preoperative Glasgow Coma Scale <15.